Globus Medical buys NuVasive in all-stock for $3.1 billion
Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1
Drugs
Medical
Pharma
Drugs
Pharma
FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers
The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according
Climate
Health
Medical
Turkey, Syria quake toll crosses 20,000, global agencies call for new aid routes
About 14 trucks carrying relief materials reached opposition-held areas in Syria from Turkey, through the only authorized route for aid deliveries to quake-struck
Drugs
Pharma
Abbott to acquire Cardiovascular Systems for $890 million
Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.
Drugs
Pharma
Lupin gets FDA nod for injection to lessen saliva, stomach acid
Lupin Limited, an Indian maker of branded, generic formulations, biotechnology products, and active pharmaceutical ingredients, has got USFDA approval for its ANDA injection,
Drugs
Pharma
CVS set to acquire Oak Street Health for $10.6 billion in cash
CVS Health, a US healthcare company, is set to acquire Oak Street Health in an all-cash deal valued at $10.6 billion, according to
Climate
Drugs
Pharma
H5N1 influenza’s spread to mammals needs ‘close monitoring’
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged
Climate
Health
Time running out for quake survivors in Turkey, Syria
Time was running out for the survivors of the earthquakes that struck Turkey and Syria as health agencies and organisations called for urgent
Health
Medical
WHO boss Tedros wants to ‘banish’ trans fats
Nine of the 16 countries with the highest estimated proportion of coronary heart disease deaths caused by trans fat still do not have